Seamless Sight – The Synchrony Dual Optic accommodating lens implant The Synchrony accommodating implant allows patients to see well at all distances which means near, intermediate and far without glasses or contact lenses.It is the only implant in the world which expands and contracts naturally to give a continuous change in focus without compromising the quality of vision – just like our natural lens when we are young.Your private health insurance will contribute significantly towards the cost of treatment if you have a symptomatic cataract.
Bausch Lomb acquired Crystalens in early 2008; and in June of that year, the FDA approved a “high-definition” version of Crystalens, which incorporates an optic designed for better near vision.
In 2010, Bausch Lomb introduced the Crystalens Aspheric, which has an optical design that gives it improved contrast sensitivity and reduces higher order aberrations.
This design strategy trades off some of the benefits of seeing through a single zone in order to have a greater range of focus. While many multifocal patients can read without glasses, their distance vision may not be as sharp as it might be with a monofocal IOL.
Multifocal patients often complain of seeing glare and halos, especially at night, in the first few months after surgery.
He has gained an international reputation providing the latest and most innovative new surgery and implants available in the world for his patients.
For nearly two decades, “presbyopia-correcting” intraocular lenses (IOLs) have been available to post-cataract surgery patients, but for a variety of reasons they have garnered only modest interest.
Instead of placing multiple focusing elements in a single fixed lens, most accommodating lenses change focus by utilizing a single optical element that moves like a camera lens or alters shape.
Typically, the eye’s “focusing” or ciliary muscle powers the movement or shape change.
As a result, currently approved accommodating lenses typically can’t provide a full range of vision.
IOL developers continue to investigate new accommodating designs in hopes of gaining enough accommodation to provide sharp vision at all distances.
A Review of the Current Pipeline THE APPROVED Crystalens® and Trulign® Toric (both by Bausch Lomb) are currently the only FDA-approved IOLs that can be described as accommodating.